Related Experiment Video

Updated: Sep 20, 2025

Improving IV Insulin Administration in a Community Hospital
12:08

Improving IV Insulin Administration in a Community Hospital

Published on: June 11, 2012

19.0K

Promoting glycemic control in young children with type I diabetes: Results from a pilot intervention for parents

Eleanor R Mackey1, Carrie Tully1, Meredith Rose1

  • 1Department of Psychology and Behavioral Health, Children's National Hospital.

Families, Systems & Health : the Journal of Collaborative Family Healthcare
|June 6, 2022
PubMed

Insights

The type One Training (TOTs) program shows promise for improving nutrition and physical activity in young children with type 1 diabetes (T1D), demonstrating feasibility and acceptability in a pilot study.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Behavioral Science

Background:

  • Type 1 diabetes (T1D) management in young children requires careful attention to nutrition and physical activity.
  • Developmental challenges can complicate T1D management related to diet and exercise.
  • A pilot study investigated an intervention to enhance nutrition and physical activity in this population.

Purpose of the Study:

  • To evaluate the feasibility and acceptability of the type One Training (TOTs) program.
  • To assess indications of behavior change in nutrition and physical activity for young children with T1D.
  • To determine the impact of the TOTs program on glycemic control and behavioral outcomes.

Main Methods:

  • A pilot randomized controlled trial involving 36 parents of children aged 2-5 years with T1D.
  • Participants were assigned to either the TOTs program or Usual Care (UC).
  • Outcomes included feasibility metrics, acceptability ratings, glycemic variability, nutritional intake, physical activity, and behavioral assessments.

Main Results:

  • The TOTs program was feasible to administer with high completion rates and very high acceptability.
  • Children in the TOTs group showed improved glycemic control (increased time in target range) and reduced feeding problems.
  • The Usual Care group experienced a decrease in moderate to vigorous physical activity.

Conclusions:

  • The TOTs program is a feasible and acceptable intervention for young children with T1D.
  • Preliminary findings suggest potential benefits for glycemic control and behavior.
  • Future research should focus on efficacy and tailoring the intervention for optimal impact.
Abstract

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

2.9K
A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

9.1K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
415
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
276
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
356
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.3K